06/02/2025
6:10 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
8:00 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:23 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
3:16 PM | BioXcel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2025
3:32 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:30 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
04/01/2025
5:08 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:02 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:02 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:06 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:07 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
4:00 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
5:35 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:36 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:37 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:38 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
8:21 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:51 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
03/03/2025
7:42 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
BioXcel Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/06/2025
7:44 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
4:28 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2025
11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
01/16/2025
7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
7:03 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2025
7:04 AM | BioXcel Therapeutics (Issuer)
Patni Rajiv (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:01 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:03 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:45 PM | BioXcel Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
6:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form DEF 14A | |
12/18/2024
7:19 PM | BioXcel Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SCHEDULE 13G | |
12/18/2024
4:16 PM | BioXcel Therapeutics (Filer)
| Form PRE 14A | |
12/18/2024
4:20 PM | BioXcel Therapeutics (Subject)
Qatar Investment Authority (Filed by)
| Form SCHEDULE 13G | |
Want to front-run Warren Buffett? (Ad) A Historic Gold Announcement Is About to Rock Wall Street?
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Click here to get Garrett’s Top Four picks now. |
12/17/2024
5:10 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:03 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:04 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:06 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:08 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:21 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:33 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144/A | |
12/16/2024
2:23 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
2:00 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
1:10 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
3:05 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/25/2024
3:06 PM | BioXcel Therapeutics (Issuer)
MACK DAVID J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:00 AM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
3:43 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
3:46 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
11/14/2024
8:10 AM | BioXcel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:08 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
8:53 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:54 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
8:55 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:33 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:40 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:17 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:17 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4/A | |
09/17/2024
6:18 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:19 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:20 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:21 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
6:23 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:42 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:26 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:16 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
2:48 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
1:58 PM | BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
12:23 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
9:47 AM | BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
09/09/2024
3:15 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:16 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2024
3:41 PM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
8:22 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4/A | |
06/18/2024
8:24 PM | BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad) Tesla's About to Prove Everyone Wrong... Again
Back in 2018, when Jeff Brown told everyone to buy Tesla…
The "experts" said Elon was finished and Tesla was headed for bankruptcy.
Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. |
06/18/2024
8:25 PM | BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:26 PM | BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
8:27 PM | BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
2:13 PM | BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:34 PM | BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
1:09 PM | BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:46 PM | BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
12:04 PM | BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buy BTAI Stock Free BTAI Stock Alerts